We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Advocacy groups and pharma companies often work hand in hand, especially in rare diseases. This year, however, saw some of the shine wear off of those close relationships as politicians and the media raised red flags over payments from pharma companies.